Jeffrey Blizard's most recent trade in Sanuwave Health Inc was a trade of 1,574 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sanuwave Health Inc | Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,574 | 1,574 | - | - | Stock Option (right to buy) | |
| TELA Bio Inc | Jeffrey Blizard | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 154,100 | 154,100 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Jeffrey Blizard | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 104,800 | 119,125 (1%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 11,700 | 11,700 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 7,950 | 14,325 (0%) | 0% | 0 | Common Stock | |
| Sanuwave Health Inc | Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 1,761 | 1,761 | - | - | Stock Option (right to buy) | |
| TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 9,300 | 9,300 | - | - | Stock Option (Right to Buy) | ||
| TELA Bio Inc | Jeffrey Blizard | Director | 04 Jun 2024 | 6,375 | 6,375 (0%) | 0% | 0 | Common Stock |